Is it ok for me to take a second hpv test just two months after?

by Rachel on January 28, 2011

I took the hpv test and didnt get a shot. Now I am starting to think I might have caught it. Since I didnt get the shot I think I have a higher risk. I just took the test 2 months ago do you think it is ok for me to get another one this soon? What do you suggest?

{ 2 comments… read them below or add one }

sarah January 28, 2011 at 11:45 am

I’m not quite sure how long after you’ve been exposed to hvp that it takes to show up in a test, however have you had new sexual partiners? Most of the time though women don’t even know that they have it, they don’t have any symptoms.

Also the Gardisil injection only protects you from 4 strains of the HPV virus, so even with the injection you can still obtain HPV.

I would call you doctor and talk to them and see what they recommend.

tarnishedsilverheart January 28, 2011 at 12:37 pm

An HPV test again two months after having sex with a high risk person…probably will not yield correct information. The virus may take many months to show or it can take years…never really knowing where you acquired your virus if you have had more than one sex partner.

Most often a person does not show any signs or symptom of the virus…if you are having any signs…then yes explain this to your doctor…and he may even recommend another Pap test..

The vaccine is given in 3 injection….so it would be six months before you receive protection from the 4 HPV type that it prevents…and if you had sex with any before the virus then you may have already acquire the virus…the vaccine is not as effective if given after you have engaged in sex. They are 15 high risk HPV type…and the vaccine only prevent two….so even after receiving all 3 injection….receiving the vaccine before any sex….you still can acquire an HPV type the vaccine does not prevent.

Yearly Paps with HPV screening helps our doctor find abnormal cells quickly…but again it can take years for abnormal cells to develop…and a Pap test can miss abnormal cell changes…

This article follow a group of women…and explains the six month pap smear

Persistent HR-HPV infection potential endpoint for HPV clinical studies
By Ingrid Grasmo
23 March 2009
Cancer Epidemiology Biomarkers and Prevention 2009; 18: 854-62
MedWire News: Canadian researchers have provided the first actuarial estimate of
mean time between incident high-risk (HR)-human papilloma virus (HPV) infection
in previously uninfected women and onset of cervical lesion development.
“Persistent HR-HPV infection, particularly HPV 16/18, is a strong predictor of
cervical lesion risk and potentially a reliable endpoint for clinical HPV
research,” comment Eduardo Franco (McGill University, Montreal, Quebec, Canada)
and colleagues.
The researchers included 553 women with a mean age of 20.8 years who, at study
entry, were cytologically negative, HPV 16/18 seronegative, and HR-HPV DNA
negative. Cervical samples were collected at 6-month intervals.
Following a first incident infection with HPV 16/18 and other HR-HPVs, the mean
time to detection of squamous intraepithelial lesion (SIL) or cervical
intraepithelial neoplasia (CIN) was 43.3 and 46.4 months, respectively.
Most (65 percent) of the 51 women with an HPV 16/18 infection lasting more than
6 months developed SIL/CIN.
All associations of SIL and CIN with HPV infection were of very high magnitude,
with the strongest associations seen with persistent HPV 16/18 infection lasting
for a minimum of two 6-monthly visits (odds ratio = 169.0). The relative risks
for SIL/CIN following incident HPV infection were 66.2 for HPV 16/18 and 50.9
for other HR-HPVs.
The authors say that it is “clear that two- [6 monthly] visit definition of
persistence was sufficient to distinguish lesion risk between very transient
episodes and that resulting from infections of longer duration.”
MedWire ( is an independent clinical news service provided
by Current Medicine Group, a part of Springer Science+Business Media. © Current
Medicine Group Ltd; 2009

Cervical HPV infection is a common sexually transmitted infection. Most women are infected shortly after beginning their first sexual relationship,[6] with the highest prevalence seen in women under 25 years of age.[7,8] Thereafter, prevalence decreases rapidly. In young and middle-aged women, HPV infections are usually transient, at least when their duration is measured by how long the virus can be detected in cytological samples.[9,10,11] Virus might be detected only intermittently; and the concurrent or sequential detection of different HPV types is common.[12-
Following infection, HPV enters a period of quiescence that lasts about 2-12 months. Most HPV infections resolve without symptoms (subclinical) at this stage, presumably due to the emergence of the host’s cell-mediated immune response beginning approximately 3 months after infection (Figure 17). This immune response either eradicates the virus or suppresses it to non-detectable levels. Therefore, it is not yet known whether an HPV infection that appears to have cleared clinically is really eradicated or simply remains below the sensitivity level for detection with current molecular techniques.
Some HPV infections are thought to be suppressed and their genomes maintained in a long-term latent state (i.e., subclinical infection with a very small group of cells presumably maintaining infection at low DNA copy numbers). Support for a latent state for HPV infection comes from the observation that in some women genital warts can resolve spontaneously only to recur (i.e., reactivate) during pregnancy or when the immune system becomes compromised (e.g., HIV infection). It is not yet clear how commonly latency occurs in immunocompetent host

Leave a Comment

Previous post:

Next post: